H.I.G. Capital
Middle market buyouts, add-ons and growth deals in U.S. business services, IT services, healthcare and industrials, plus a fund for under $15M EBITDA.
Latest deal Oct 2026
Buyers by sector
Healthcare services is one of the broadest and most active areas for private equity. It covers physician and therapy practices, home health and hospice, behavioral health, staffing, outsourced billing and many specialty providers in between. Demand is driven by an aging population and by insurers and health systems looking for lower-cost places to deliver care, which makes well-run independent providers attractive to buyers.
Most of the buyers below build platforms and then add practices or providers in the same specialty or region. A smaller practice will usually join one of those platforms rather than become a new investment on its own. Some firms focus on businesses that sell services to hospitals, insurers and employers rather than to patients, such as billing, coding, staffing or medical transportation. Those carry different risks from direct patient care and are often valued differently.
Healthcare diligence goes deeper than in most sectors. Buyers will look at the mix of commercial insurance, Medicare and Medicaid, reimbursement rates and recent changes to them, billing and coding accuracy, licensing and accreditation, and compliance with the rules on referrals and patient privacy. In physician practices, they will also look at how many providers produce the revenue and how those providers are paid, since that drives both value and deal terms.
Many states limit who can own a medical practice, so deals with physician groups often use a management company structure. The buyer owns the business operations, and an entity owned by physicians employs the clinicians. Owners should ask how that will work for them, what their pay will be after the sale, how much equity they will be asked to roll into the platform, and what non-compete terms the buyer expects.
Greymont is paid by buyers, never by owners. Greymont can help you work out which of these firms are building platforms in your specialty, and what joining one would mean for you and your providers.
Middle market buyouts, add-ons and growth deals in U.S. business services, IT services, healthcare and industrials, plus a fund for under $15M EBITDA.
Latest deal Oct 2026
Minority and majority growth equity of $10M to $500M in profitable tech, healthcare and business services companies in North America and Europe.
Latest deal Oct 2026
Control and large minority deals of $50M to $200M in healthcare and tech-enabled services, including IT managed services and HOA property management.
Latest deal Oct 2026
Large buyouts, take-privates and growth deals in consumer, healthcare and business services, distribution and industrials. Smaller firms fit as add-ons.
Latest deal Oct 2026
Control buyouts of founder-owned education, healthcare, technology and professional services firms with $3M+ EBITDA, grown through add-ons.
Latest deal Oct 2026
Majority or minority deals in founder-owned essential services and distribution companies with $3M to $15M of EBITDA, often as the first outside investor.
Latest deal Oct 2026
Buyouts and growth equity of $50M to $200M in North American software, healthcare, information, communications and business services firms.
Latest deal Oct 2026
Healthcare-only investor buying device, pharma services and healthcare tech services companies through carve-outs, take-privates and add-ons.
Latest deal Oct 2026
Control buyouts, add-ons and growth deals in aerospace and defense, government services and IT, and healthcare; closed a $6.0B fund in 2025.
Latest deal Oct 2026
Control and large minority stakes in services, healthcare, industrial and tech companies worth $150M to $3B, plus add-ons through its platforms.
Latest deal Oct 2026
Control buyouts of IT, insurance, professional and business services companies; its Heritage fund writes $20 million to $60 million checks.
Latest deal Oct 2026
Control buyouts and growth equity of $75M to $500M+ in healthcare, industrial, business services and consumer companies, three or four platforms a year.
Latest deal Oct 2026
Control, minority or debt capital for US business services, software, insurance and healthcare companies with $2M to $10M of EBITDA.
Latest deal Oct 2026
Control buyouts and steady add-ons in specialty materials, chemicals, industrial technology, pharma services and healthcare services.
Latest deal Oct 2026
Majority stakes in founder- and family-owned services, technology and industrial companies with up to $15M EBITDA, plus many small add-ons.
Latest deal Oct 2026
Control buyouts of founder, family and carve-out businesses in consumer, software, industrial and healthcare; a credit arm offers non-control capital.
Latest deal Oct 2026
Control and growth investments in healthcare services, healthcare IT and vertical software, mostly large, plus add-ons for its platforms.
Latest deal Oct 2026
Bank-backed investor writing $50M to $150M checks for control or minority stakes in family and founder-owned North American companies.
Latest deal Oct 2026
Control buyouts of companies with $5M+ EBITDA in industrial services, distribution, IT services and consumer services, plus growth deals in services.
Latest deal Oct 2026
Buy-and-build control investor in North American companies with $5M to $100M of EBITDA, plus non-control capital for sponsor-backed firms.
Latest deal Oct 2026
Majority buyouts of $5M to $30M EBITDA healthcare, industrial and aerospace companies, plus a steady run of add-ons for its platforms.
Latest deal Oct 2026
Growth equity, buyouts and recapitalizations of U.S. healthcare services companies with about $25M to $500M of revenue.
Latest deal Oct 2026
Control investments of $100M to $300M+ in data-rich software, financial services and healthcare companies with $25M to $100M of revenue.
Latest deal Oct 2026
Buy-and-build investor in business and consumer services, from accounting and consulting to commercial HVAC, landscaping, paving and healthcare.
Latest deal Oct 2026
Control buyouts of $3M to $15M EBITDA firms in business services, IT and tech services, industrial services and specialty manufacturing, plus add-ons.
Latest deal Oct 2026
Control buyouts of US service and tech firms with $3M to $25M EBITDA; prefers government contracting, healthcare and business services.
Latest deal Oct 2026
Healthcare-only buyouts and recaps in services, providers and medical manufacturing at $5M to $25M EBITDA, plus a healthcare software fund.
Latest deal Oct 2026
Majority stakes alongside founders in business services, logistics and specialty industrial companies with $5M to $40M+ of EBITDA.
Latest deal Oct 2026
Buyouts of services, healthcare, consumer, industrial and tech services companies with up to $80M of EBITDA, plus frequent add-ons to its platforms.
Latest deal Oct 2026
Majority buyouts of healthcare and services companies with $50M to $250M of EBITDA, plus add-ons for platforms such as AWP Safety and Riveron.
Latest deal Oct 2026
Non-control junior capital: $5M to $30M of subordinated debt plus preferred or common equity for owner-run companies with $2M+ EBITDA.
Latest deal Oct 2026
Very active lower middle market buyer: control deals up to $35M EBITDA, minority and growth capital, and many add-ons in IT, home and safety services.
Latest deal Oct 2026
Research-led buyouts of niche manufacturing, distribution and service companies with $2M to $15M of EBITDA, grown through add-ons.
Latest deal Oct 2026
Majority recaps of $100M to $500M services and industrials companies with $50M to $150M equity checks, plus frequent add-ons for its platforms.
Latest deal Oct 2026
Healthcare-only buy and build investor in multi-site provider groups and outsourced services, with $30M to $100M equity checks, mostly control.
Latest deal Oct 2026
Buyouts, minority and structured deals of $100M to $300M in healthcare and business services, including IT managed services, roofing and HVAC.
Latest deal Oct 2026
Control buyouts and add-ons in consumer brands, food, home and commercial services, and healthcare services across North America.
Latest deal Oct 2026
Majority or minority stakes of $30M to $125M in companies with $15M+ revenue where managers keep a real stake; software, consumer, staffing, finance.
Latest deal Oct 2026
Buys and combines industrial, healthcare and technology companies with $10M to $150M of EBITDA in North America and Western Europe.
Latest deal Oct 2026
Control buyouts of U.S. healthcare, education and financial services companies with about $10 million to $100 million of EBITDA.
Latest deal Oct 2026
Buyouts and recapitalizations of Southeastern business, consumer and healthcare services companies with at least $3M of EBITDA.
Latest deal Sep 2026
Middle market buyouts at $25M to $750M enterprise value in services, distribution, software and light manufacturing; no minimum size for add-ons.
Latest deal Sep 2026
Growth buyouts of $100M to $1B in financial services, healthcare solutions and business and tech services, with heavy use of add-on acquisitions.
Latest deal Sep 2026
Control and minority stakes in franchisors and multi-location service brands, from fitness to quick-lube oil change, with $3M to $30M+ EBITDA.
Latest deal Sep 2026
Growth and buyout equity of $25M to $250M+ for healthcare, insurance and essential services companies with $5M+ EBITDA, often leaving founders a stake.
Latest deal Sep 2026
Thematic investor in healthcare services, healthcare technology and business services companies with $5M to $30M of EBITDA, plus add-ons.
Latest deal Sep 2026
New York firm taking mostly control stakes in tech-enabled business services companies with $5M+ EBITDA, from waste services to healthcare IT.
Latest deal Sep 2026
Large buyouts and executive-led builds in services, financial services, healthcare and tech; its growth fund writes checks from about $50M.
Latest deal Sep 2026
Operations-focused buyouts of companies with $3M+ EBITDA in services, consumer and industrials, plus add-ons of any size to its current platforms.
Latest deal Sep 2026
Healthcare-only control investor, often first institutional capital, for companies with $20M to $200M of revenue and $5M to $20M+ of EBITDA.
Latest deal Sep 2026
Majority buyouts of US services companies with $1M to $10M of EBITDA, usually run afterward by a Broadtree operating partner as CEO.
Latest deal Sep 2026
Control deals for companies with $4M to $25M of EBITDA in healthcare, business services and IT services, with heavy add-on buying.
Latest deal Sep 2026
Majority recaps and buyouts of owner-run business services, specialty manufacturing and consumer companies with $3M to $15M of EBITDA.
Latest deal Sep 2026
Healthcare-only buyouts and growth equity in North America, with $25M to $100M+ equity checks in services, healthcare IT and diagnostics.
Latest deal Sep 2026
Pittsburgh SBIC investor: junior capital for $3M to $10M EBITDA buyouts led by others, plus control buys of $2M to $6M EBITDA family businesses.
Latest deal Sep 2026
Majority stakes in large family and founder-owned companies in distribution, industrials, services and healthcare; smaller firms join as add-ons.
Latest deal Sep 2026
Growth and buyout investor in software, healthcare, fintech and tech-enabled services; $5M+ revenue and $10M to $200M of equity, majority or minority.
Latest deal Sep 2026
Invests $10M to $50M of debt, minority or control equity in manufacturing, distribution, healthcare and business services firms with $2M+ cash flow.
Latest deal Sep 2026
Control investments of $50M to $200M+ in North American companies with measurable impact in healthcare, education and climate.
Latest deal Sep 2026
Control investments in U.S. healthcare, business and industrial service companies with up to $20M EBITDA, grown through add-on acquisitions.
Latest deal Sep 2026
Buyouts, carve-outs and take-privates of companies worth $100 million to $2.5 billion in industrials, logistics, healthcare and consumer.
Latest deal Sep 2026
Control and minority deals in insurance, wealth management, accounting, specialty finance and healthcare businesses with $10M to $100M of EBITDA.
Latest deal Sep 2026
Chicago firm investing its own capital deal by deal: buyouts, minority and growth stakes, mostly in education, healthcare services and consumer brands.
Latest deal Sep 2026
Majority and minority deals for North American companies worth $200M to $2B in services, healthcare, industrials and technology.
Latest deal Sep 2026
Baltimore-area growth equity firm putting $5M to $15M into software and tech-enabled services companies with $10M to $50M+ of revenue and 20% growth.
Latest deal Sep 2026
Control buyouts of companies with $20M to $50M of EBITDA in consumer services, industrials and tech, plus add-ons like car washes and lawn care.
Latest deal Sep 2026
Five lower middle market strategies: majority buyouts of tech-enabled services, mezzanine debt with equity, and growth equity in software and healthcare.
Latest deal Sep 2026
Majority recapitalizations of $5M to $25M EBITDA business, industrial and healthcare services companies, with founders often keeping a stake.
Latest deal Sep 2026
Control buyouts in business services and industrials, plus a lower middle market strategy for founder- and family-led companies.
Latest deal Sep 2026
Healthcare investor building specialty practice groups (eye, dental, veterinary, dermatology), value-based senior care, health tech and senior living.
Latest deal Sep 2026
Healthcare sponsor that forms owner-owned platforms for oral surgery and med spa practices; owners join and keep equity instead of selling.
Latest deal Sep 2026
Majority and minority deals in business services, tech, healthcare and consumer companies with $5M+ EBITDA and $50M to $500M in enterprise value.
Latest deal Sep 2026
Majority growth buyouts of founder-owned healthcare, education and tech-enabled services companies with $2M to $15M EBITDA; $10M to $40M equity checks.
Latest deal Sep 2026
Growth equity checks of $20M to $125M for founder-led software and healthcare companies with $10M+ revenue, 20%+ growth and breakeven or better.
Latest deal Sep 2026
Buyouts and frequent add-ons in software and services up to $50M EBITDA, including HVAC, MSPs, property management, roofing and accounting.
Latest deal Sep 2026
Healthcare-only buyer of provider, payor and life sciences outsourcing companies, investing $75M to $150M of equity per platform plus add-ons.
Latest deal Sep 2026
Control and growth investments in larger financial services, software, healthcare and industrial companies, mainly in North America.
Latest deal Sep 2026
Control buyouts of growing lower middle market healthcare, software and consumer brand companies with up to $30 million of EBITDA.
Latest deal Sep 2026
Seattle growth-buyout firm taking majority stakes in B2B industrial, distribution and service companies with $4M to $20M of EBITDA.
Latest deal Sep 2026
St. Louis buyer of founder-led software, healthcare and service companies with $5M to $50M EBITDA; frequent pest control and inspection add-ons.
Latest deal Sep 2026
Healthcare-only buyouts: controls middle market providers, pharmacy, pharma services and health IT companies, then adds on; $2.3B Fund XI.
Latest deal Sep 2026
Health care only: large take-privates and buyouts of providers, services and distributors, plus growth rounds for drug and device companies.
Latest deal Sep 2026
Control and minority stakes in large services companies in the US and Europe; smaller firms usually join as add-ons to platforms like EisnerAmper or CBTS.
Latest deal Sep 2026
Control buyer of industrial manufacturers, industrial service firms and distributors, from loss-making up to $40M of EBITDA, with checks up to $150M.
Latest deal Sep 2026
Growth equity and buyouts in software, healthcare IT, fintech and tech-enabled services; $7M+ revenue, $20M to $400M equity checks.
Latest deal Sep 2026
Non-control debt and minority equity of $5M to $60M for U.S. and Canadian owner-led companies with $4M+ EBITDA; owners keep control.
Latest deal Sep 2026
Majority investments in services businesses such as healthcare staffing, landscaping, restoration and fire protection, grown through add-ons.
Latest deal Sep 2026
Majority and growth investments in wealth management, insurance, accounting and healthcare services businesses, built out through frequent add-ons.
Latest deal Sep 2026
Growth equity checks of $150M to $600M, minority or majority, in profitable software, financial services, healthcare and business services companies.
Latest deal Sep 2026
Majority or minority stakes in financial services and tech firms worth $75M to $2.5B, plus add-ons of any size in insurance, payroll, wealth and software.
Latest deal Sep 2026
Control buyouts of $100M to $500M in defensive growth niches such as healthcare, software and business and infrastructure services, plus minority stakes.
Latest deal Sep 2026
Majority and minority growth investments of $100M to $750M in fast-growing software, healthcare, financial, business services and consumer companies.
Latest deal Sep 2026
Control buyouts with $100M to $400M equity checks in fiber internet, insurance and wealth services, and essential business and home services.
Latest deal Sep 2026
Control buyouts and minority stakes in tech-enabled financial services, healthcare and software companies, with frequent wealth management add-ons.
Latest deal Sep 2026
Control deals mixing debt and equity in US and European business services, franchising, education and engineered products firms with up to $250M revenue.
Latest deal Aug 2026
Midmarket buyouts, carve-outs and recapitalizations in business services, consumer, healthcare services and industrials, up to $65M of EBITDA.
Latest deal Aug 2026
Permanent-capital holding company buying family businesses, carve-outs and special situations worth up to $1B; building a facility services group.
Latest deal Aug 2026
Control buyouts and frequent add-ons in waste and environmental services, healthcare services, and light manufacturing and automotive.
Latest deal Aug 2026
Healthcare-only investor putting $50M to $150M or more into services companies at a turning point, mostly for control, sometimes minority.
Latest deal Aug 2026
Control buyouts of niche-leading North American firms with $2M to $15M of EBITDA, mostly specialty manufacturing, plus add-ons from $1M EBITDA.
Latest deal Aug 2026
Majority stakes in founder and physician-owned healthcare businesses with $1M to $10M EBITDA, from dental and behavioral health to healthcare IT.
Latest deal Aug 2026
Control and minority equity, plus growth debt, for $1M to $20M EBITDA companies in environmental services, health and supply chain software.
Latest deal Aug 2026
Control buyouts of $8M to $30M EBITDA companies in health and wellness, business services and franchising, with add-ons of any size.
Latest deal Aug 2026
Healthcare-only investor taking majority or active minority stakes in founder-owned companies with $3M+ EBITDA; $25M to $100M of equity.
Latest deal Aug 2026
Healthcare-only buyouts and structured capital across services, products and distribution, from a $5.4B buyout fund and a $400M structured fund.
Latest deal Aug 2026
Majority buyouts of services firms with $2M to $10M EBITDA, grown by add-ons in roofing, restoration, biohazard cleanup and healthcare services.
Latest deal Aug 2026
Debt and equity in one package, often a minority recap, for owner-run firms with $10M to $150M revenue and $3M to $20M EBITDA; no fund deadline to sell.
Latest deal Aug 2026
Founder-owned companies with $4M to $30M+ of EBITDA; its Private IPO pays owners up to 80% in cash while they keep voting control.
Latest deal Aug 2026
Boston buyer of large healthcare, financial and essential services, and technology companies, with more than 700 add-ons across its portfolio.
Latest deal Aug 2026
Sector funds for small healthcare, food, business services and industrial firms; platforms at $1M to $10M EBITDA, add-ons from $1M of revenue.
Latest deal Aug 2026
Control deals in healthcare companies with $10M to $100M of revenue: care delivery, consumer health, pharma services and health software.
Latest deal Aug 2026
Generalist buyer of North American companies with $5M to $25M of EBITDA, investing $30M to $125M of equity, plus add-ons of any size.
Latest deal Aug 2026
Chicago buyout and growth investor in accounting, insurance, wealth and other financial services, healthcare, and federal IT and software.
Latest deal Aug 2026
Debt and equity of $10M to $40M for founder-led services, healthcare and software firms, as a minority or majority partner and often the first outside investor.
Latest deal Aug 2026
Majority or minority stakes in western founder and family-owned firms with $10M to $50M of earnings; light debt and 5 to 12 year holds.
Latest deal Aug 2026
Buyouts and growth deals in U.S. and Canadian consumer and distribution companies with $10M to $50M of EBITDA; add-ons of any size.
Latest deal Aug 2026
Services-only buyer: business, healthcare and consumer services with $15M to $150M revenue and $4M to $25M EBITDA; add-ons of any size.
Latest deal Aug 2026
Flexible debt and equity for founder-owned healthcare, business services and education companies with $3M to $15M EBITDA; $20M to $50M checks.
Latest deal Aug 2026
Healthcare-only investor buying majority stakes in profitable tech-enabled healthcare services companies through buyouts, recaps and growth deals.
Latest deal Aug 2026
Flexible equity and structured capital of $10M to $35M for founder and family companies under $20M EBITDA, often alongside independent sponsors.
Latest deal Aug 2026
Control buyouts of US firms with $2M to $10M EBITDA in services, IT, distribution, light manufacturing and e-commerce; add-ons from $300K EBITDA.
Latest deal Aug 2026
Majority or minority stakes in tech-enabled business services and IT services companies, typically with $7M to $30M of EBITDA.
Latest deal Aug 2026
Consumer-only investor: majority buyouts with $250M+ equity checks and $10M to $100M growth stakes in US brands, restaurants and consumer services.
Latest deal Aug 2026
Control and lead minority deals, up to $500M of equity, in business services, healthcare and industrial services, plus frequent add-ons.
Latest deal Aug 2026
Control-agnostic growth investor: $20M to $100M of equity in founder-owned IT services, software, business services and healthcare outsourcing firms.
Latest deal Aug 2026
Control and non-control deals in business services, consumer services and healthcare, with $5M to $30M of EBITDA and $25M to $150M equity checks.
Latest deal Aug 2026
Buy-and-build investor in industrials, business services and healthcare with $3M to $40M of EBITDA; no minimum size for add-ons.
Latest deal Jul 2026
Control or minority deals for companies with $100M+ revenue, profitable or not: founder-owned firms, carve-outs, turnarounds and take-privates.
Latest deal Jul 2026
Control buyouts of North American services companies with $5M to $15M of EBITDA, focused on healthcare billing, outsourcing and managed IT.
Latest deal Jul 2026
Control and minority deals for founder and family-owned companies with $1M+ of EBITDA in the U.S. and Canada, plus add-ons from $1M of revenue.
Latest deal Jul 2026
Buyouts and growth capital for healthcare services and multi-unit consumer chains with $3M to $15M+ of EBITDA, often as first institutional capital.
Latest deal Jul 2026
Control and growth deals in physician-led, multi-site healthcare services companies with $20M to $100M of revenue and $2M to $10M of EBITDA.
Latest deal Jul 2026
Control buyouts, structured capital and small cap deals across industries, investing up to $250M per platform, with active add-on programs.
Latest deal Jul 2026
Majority investor that builds US healthcare services platforms, putting $40M to $60M of equity into companies with up to about $10M EBITDA.
Latest deal Jul 2026
Control investor in wealth management, insurance brokerage, accounting, healthcare and fintech firms with $10M+ EBITDA; its platforms buy smaller firms.
Latest deal Jul 2026
Control buyouts of family and founder-owned firms with $1M to $6M of EBITDA, mainly outsourced services to local governments, plus niche manufacturing.
Latest deal Jul 2026
Technology-led buyouts of large US healthcare, industrial and business services companies; smaller firms join as add-ons to Mavis, Harbor or Relation.
Latest deal Jul 2026
Healthcare-only investor in companies with $5 million to $30 million of EBITDA, using founder recaps, buyouts, minority stakes and carve-outs.
Latest deal Jul 2026
Healthcare-only buyer of mid-sized consumer health, medical device, pharma services and health tech businesses in North America and Europe.
Latest deal Jul 2026
Control buyouts and non-control preferred equity in larger services and healthcare companies with $25M to $300M of EBITDA, including waste.
Latest deal Jul 2026
Control buyouts of North American companies with $10M to $50M EBITDA in government services, healthcare, industrial and business services.
Latest deal Jun 2026
Non-control structured capital: $7.5M to $25M of debt and equity for owner-managed US companies with $10M+ revenue and about $2M+ EBITDA.
Latest deal Jun 2026
Buyouts and growth deals in healthcare, industrials and outsourced services, including managed IT, at $10M to $100M+ of EBITDA.
Latest deal Jun 2026
Control buyouts of North American industrial and services companies with $200M to $2B of revenue, plus add-ons through its platforms.
Latest deal May 2026
Debt plus minority equity of $10M to $30M for companies with $10M+ revenue and $3M to $15M EBITDA, often alongside independent sponsors.
Latest deal May 2026
Control recapitalizations of founder-owned US and Canadian firms with $10M to $100M of revenue and $3M to $15M of EBITDA, plus add-ons.
Latest deal May 2026
Majority and growth investments in software, IT services, cybersecurity, healthcare and industrial tech companies valued up to about $250 million.
Latest deal May 2026
Control buyouts of consumer and services companies with $4M to $15M of EBITDA, plus mezzanine and equity for growth through SBJ Elevation.
Latest deal May 2026
Majority and control investments in healthcare providers, services and technology companies with $5M to $25M of EBITDA.
Latest deal May 2026
Founder-focused buy and build investor in business services, healthcare and property management in the US and Europe, plus a restaurant growth fund.
Latest deal May 2026
Healthcare services only: $10M to $50M of equity for control buyouts, buy-and-build platforms and new companies led by proven operators.
Latest deal May 2026
Control or minority investments of $3M to $8M in US companies with $5M to $50M of revenue and at least $1M of EBITDA.
Latest deal May 2026
Healthcare-only growth and lower middle market investor that often co-invests with other firms, backing value-based care, services and health IT.
Latest deal May 2026
Healthcare services buyouts and growth deals at $5M to $30M EBITDA, plus add-ons for home care, infusion, orthopedic and pediatric dental platforms.
Latest deal Apr 2026
Healthcare-only investor backing founder-led, EBITDA-positive healthcare services and health tech companies worth up to $100M.
Latest deal Apr 2026
Control investments in founder-owned consumer and commercial services companies in the Southeast and Texas with $2M to $20M of EBITDA.
Latest deal Apr 2026
Control buyouts, recaps and growth capital for companies with $50M to $500M of revenue in distribution, manufacturing, healthcare and financial services.
Latest deal Apr 2026
Middle market buyouts and add-ons in healthcare services, essential services such as propane and franchising, and specialty manufacturing.
Latest deal Apr 2026
Healthcare-only investor taking majority and minority stakes in growing healthcare services and technology companies, backed by health systems and payers.
Latest deal Apr 2026
Control buyouts of larger middle market companies in business services, healthcare, industrials and tech, with $75M to $350M equity checks.
Latest deal Apr 2026
Non-control lender and preferred equity investor for US companies with $5M to $75M of EBITDA, up to $350M per deal, often alongside PE sponsors.
Latest deal April 2026
Healthcare-only buyer: control platforms and frequent add-ons in healthcare services, health tech and wellness, with $50M to $500M of equity per platform.
Latest deal April 2026
Control deals in services firms with $7M to $25M EBITDA, mostly in the Mountain West and Southwest, plus growth equity in software firms with $3M to $15M sales.
Latest deal Mar 2026
Consumer-only growth investor: minority or majority stakes of $50M to $250M+ in brands and multi-unit businesses with $5M to $50M+ EBITDA.
Latest deal Mar 2026
Two strategies: Flagship buys firms with $10M-$75M EBITDA; Heritage backs B2B and industrial firms with $3M-$12M EBITDA. Frequent add-ons.
Latest deal Mar 2026
Control investments of $75M to $200M in North American healthcare services and software companies, usually grown through many add-ons.
Latest deal Feb 2026
Debt and equity, control or minority, for US healthcare and business services firms with $1M+ EBITDA; checks of $10M to $25M.
Latest deal Feb 2026
Nashville healthcare investor that builds new care companies and also takes majority or growth stakes in established provider businesses.
Latest deal Feb 2026
Majority buyouts of companies with $3M to $40M of EBITDA in home and business services, IT managed services, industrials and healthcare.
Latest deal February 2026
Buyouts and minority deals for niche leaders with up to $100M of revenue in business services, healthcare services, specialty industrials and consumer.
Latest deal Jan 2026
Growth equity of $10M to $40M for bootstrapped, profitable vertical software and healthcare services companies in the US and Canada.
Latest deal Jan 2026
Backs search fund entrepreneurs buying one profitable company with about $2M to $4M of EBITDA from an owner ready to step away; industry neutral.
Latest deal 2026
Backs search fund entrepreneurs who buy and run one small company; leads investor groups and puts $1M to $3.5M into each deal, in almost any industry.
Latest deal 2026
Operations-focused buyouts of profitable companies with $5M to $15M of EBITDA in healthcare, manufacturing, consumer staples and environmental services.
Latest deal Nov 2025
Healthcare-only investor backing services and technology companies through new platforms, growth rounds and add-ons to current holdings.
Latest deal Nov 2025
Majority and minority deals in multi-unit, franchised and services businesses with $3M to $50M EBITDA, from restaurants to car washes and roofing.
Latest deal Nov 2025
Control buy-and-build investor in companies with $1M to $5M of EBITDA, focused on dental, vet and other practice support groups, HVAC and insurance.
Latest deal Nov 2025
Buys 90 to 100% of software, healthcare, government and B2B services firms with $1M to $5M EBITDA, installing a CEO from its own program.
Latest deal Oct 2025
Permanent-capital investor putting $25M to $100M into lower middle market buyouts, recaps, growth deals and minority stakes, with no exit deadline.
Latest deal Oct 2025
Majority control of Texas-area founder and family firms with $2M to $10M EBITDA in real estate services, aerospace and home health; no fixed hold period.
Latest deal Aug 2025
Control investments of $25M to $50M in U.S. healthcare services companies with $2M+ EBITDA that serve rural, urban and tribal communities.
Latest deal May 2025
Growth equity, majority or minority, for founder-run software, healthcare IT and fintech companies with $5M+ of revenue.
Latest deal Apr 2025
Atlanta control buyer of Southern business services, healthcare, niche manufacturing and distribution companies with $5M to $30M of EBITDA.
Latest deal Apr 2025
Minority or majority stakes of 30% to 70% in founder-led consumer, multi-site, industrial and healthcare companies, with low debt and long holds.
Latest deal Mar 2025
Control buyouts of lower middle market companies with $25M to $250M revenue in business services, consumer, food and healthcare.
Latest deal Jan 2025
Family office that backs search fund entrepreneurs buying one US or Canadian company, usually worth $10M to $30M, and stepping in as CEO.
Latest deal 2025
Backs search fund entrepreneurs buying one stable, profitable company with $1.5M to $5M+ EBITDA from an owner ready to step away; industry neutral.
Verified Oct 2026
Long-term, low-debt investor in founder-owned essential service firms with $1M to $20M EBITDA; owns Collision Leaders and Intermountain Home Services.
Verified Oct 2026
Family office buying control of small business services, manufacturing and distribution companies with up to $15M of equity; open to retiring owners.
Verified Oct 2026
Backs solo searchers who each buy one US company to run as CEO, with equity from SFA's own committed fund; mostly service businesses so far.
Verified Oct 2026
Buys or backs established small companies with $1M+ of operating earnings and values under $25M, investing up to $5M of its partners' own money.
Verified Oct 2026
Backs search fund entrepreneurs who buy and run one established company, mostly in software, healthcare, tech-enabled and B2B services.
Verified Oct 2026
For business owners
We work for the buyers, so owners never pay us a fee or a share of proceeds. Find out how ready your business is in four minutes, or start a confidential conversation.